main-logo

ICD-10 Code C95.91 | Leukemia, unspecified, in remission Symptoms, Diagnosis, Billing

Leukemia, unspecified, in remission is a hematological malignancy characterized by the uncontrolled proliferation of abnormal white blood cells. This condition can arise from various genetic and environmental factors. Accurate coding with ICD-10 Code C95.91 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code C95.91 for Leukemia, unspecified, in remission?

ICD-10 Code C95.91 represents leukemia that is currently unspecified and in a state of remission. This code is used when the specific type of leukemia is not identified, but the patient has shown no signs of active disease. It is crucial for clinical documentation and billing to accurately reflect the patient's condition and treatment status.

ICD-10 Code C95.91 – Clinical Definition and Explanation of Leukemia, unspecified, in remission

Leukemia, unspecified, in remission, is a condition where the malignant proliferation of leukocytes has decreased significantly, resulting in an absence of symptoms and signs of active disease. This state may follow treatment such as chemotherapy or radiation. Continuous monitoring is essential to ensure that the remission is maintained.

Key Clinical Features:

  • Absence of clinical symptoms such as fatigue, fever, or bleeding.
  • Normal or near-normal blood counts.
  • Regular follow-up appointments to monitor for potential relapse.
  • Potential for long-term complications from previous treatments.

ICD-10 Code C95.91 for Leukemia, unspecified, in remission – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C95.91 is utilized to document the patient's remission status, guiding clinical assessments and treatment plans. This code aids in tracking the patient's progress and ensuring appropriate follow-up care in both acute and chronic settings.

What Does ICD-10 Code C95.91 for Leukemia, unspecified, in remission Mean in SOAP Notes?

ICD-10 Code C95.91 connects subjective reports of symptom relief and objective findings of stable blood counts to a formal diagnosis of leukemia in remission. This documentation is vital for continuity of care, supporting billing processes, and meeting EHR standards.

Treatment Options for ICD-10 Code C95.91 – Leukemia, unspecified, in remission

Management of leukemia in remission focuses on monitoring and supportive care to prevent relapse. If the condition is infectious, appropriate antibiotic therapy may be necessary.

Antibiotic Therapy:

  • First-line: Ciprofloxacin 500 mg orally twice daily for 7-14 days.
  • Alternative: Amoxicillin-clavulanate 875 mg orally twice daily for 7-14 days.
  • Consideration of prophylactic antibiotics in high-risk patients.

Supportive Care:

  • Regular blood transfusions if anemia occurs.
  • Growth factor support to stimulate blood cell production.
  • Nutritional support and counseling.

Infection Control:

  • Strict hand hygiene practices.
  • Isolation precautions during outbreaks.
  • Vaccination updates as per guidelines.

How to Document Symptoms of Leukemia, unspecified, in remission (ICD-10 C95.91) in SOAP Notes

Subjective:

  • Patient reports feeling well with no new symptoms.
  • Denies fatigue, fever, or unusual bleeding.
  • History of previous treatment and current follow-up schedule.

Objective:

  • Complete blood count shows normal white blood cell count.
  • Physical examination reveals no lymphadenopathy or splenomegaly.
  • Vital signs within normal limits.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Leukemia, unspecified, in remission (ICD-10 Code C95.91)

Assessment:

  • Diagnosis: Leukemia, unspecified, in remission.
  • ICD-10 Code: C95.91.
  • No current symptoms or signs of active disease.

Plan:

  • Continue regular follow-up appointments every 3-6 months.
  • Monitor blood counts and assess for any signs of relapse.
  • Educate patient on signs of potential complications.

Treatment & Plan Section for ICD-10 Code C95.91 – Leukemia, unspecified, in remission

  • Regular monitoring of blood counts and clinical status.
  • Education on lifestyle modifications to support health.
  • Psychosocial support and counseling as needed.
  • Follow-up imaging or lab tests based on clinical judgment.

Using ICD-10 Code C95.91 for Leukemia, unspecified, in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of remission status in Subjective (S) and Objective (O) sections.
  • Use C95.91 when the specific type of leukemia is not identified but the patient is in remission.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Include relevant CPT codes that correspond to the services provided.

ICD-10 Code C95.91 in Medical Billing and Insurance for Leukemia, unspecified, in remission

ICD-10 Code C95.91 is critical in billing for hospital, ER, or infectious disease care, ensuring accurate representation of the patient's condition.

Billing Notes:

  • Document the patient's remission status clearly to support claims.
  • Use C95.91 in settings where the specific leukemia type is not documented.
  • Include relevant clinical findings and treatment plans in the medical record.

Common CPT Pairings:

CPT CodeDescription
99213Established patient office visit, low complexity.
36415Collection of venous blood by venipuncture.
85025Complete blood count with automated differential.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C95.91 for Leukemia, unspecified, in remission

What does it mean for leukemia to be in remission?

Remission indicates that the signs and symptoms of leukemia have significantly decreased or are no longer present. This does not mean the disease is cured, but it is a positive sign that treatment has been effective.

How often should patients in remission be monitored?

Patients in remission should typically have follow-up appointments every 3 to 6 months, including blood tests to monitor for any signs of relapse or complications.

Can leukemia in remission still cause complications?

Yes, even in remission, patients may experience complications from previous treatments or may be at risk for relapse, necessitating ongoing monitoring and supportive care.

Is there a specific treatment for leukemia in remission?

Treatment during remission focuses on monitoring and supportive care rather than active treatment. This may include regular blood tests and managing any side effects from prior therapies.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved